Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1.]
W.H. Northway, R.C. Rosen, D.Y. Porter.
Pulmonary disease follo-wing respirator therapy of hyaline-membrane disease: Bron-chopulmonary dysplasia.
N Engl J Med, 276 (1967), pp. 357-368
[2.]
H.M. O'Brodovich, R.B. Mellins.
Bronchopulmonary dysplasia. Unresolved neonatal acute lung injury.
Am Rev Respir Dis, 132 (1985), pp. 694-709
[3.]
E. Bancalari, A. González.
Clinical course and lung function abnormalities during development of neonatal chronic lung disease.
Chronic Lung Dise-ase in Early Infancy, pp. 41-64
[4.]
I. Hyde, R.E. English, J.D. William.
The changing pattern of chro-nic lung disease of prematurity.
Arch Dis Child, 64 (1989), pp. 448-451
[5.]
R.A. Parker, D.P. Lindstrom, R.B. Cotton.
Improved survival accounts for some, but not all, of the increase in bronchopul-monary dysplasia.
Pediatrics, 90 (1992), pp. 663-668
[6.]
M.A. Rojas, A. González, E. Bancalari, N. Claure, C. Poole, G. Silva-neto.
Changing trends in the epidemiology and patho-genesis of neonatal chronic lung disease.
J Pediatr, 126 (1995), pp. 605-610
[7.]
S. Kotecha, M. Silverman.
Chronic respiratory complications of neonatal disorders.
Text-book of Paediatric Respiratory Medicine, pp. 488-521
[8.]
J.J. Coalson.
Pathology of chronic lung disease of early infancy.
Chronic Lung Disease in Early Infancy, pp. 85-124
[9.]
S. Arnon, J. Grigg, M. Silverman.
Pulmonary inflammatory cells in ventilated preterm neonates: Effect of surfactant treatment.
Arch Dis Child, 69 (1993), pp. 44-48
[10.]
J.R. McColm, N. McIntosh.
Interleukin-8 in bronchoalveolar lavage samples as predictor of chronic lung disease in prema-ture infants.
Lancet, 343 (1994), pp. 729
[11.]
R.L. Goldenberg, J.C. Hauth, W.W. Andrews.
Intrauterine infection and preterm delivery.
N Engl J Med, 342 (2000), pp. 1500-1507
[12.]
E.E.L. Wang, A. Ohlsson, J.D. Kellner.
Association of ureaplasma urealyticum colonisation with chronic lung disease of prema-turity; results of a meta-analysis.
J Pediatr, 127 (1995), pp. 640-644
[13.]
A. Greenough, A.D. Milner, G. Dimitriou.
Synchronised ventila-tion (Cochrane Review).
The Cochrane Library issue 1,
[14.]
V. Chan, A. Greenough, M.F. Hird.
Comparison of different rates of artificial ventilation for preterm infants ventilated beyond the first week of life.
Early Hum Dev, 26 (1991), pp. 177-183
[15.]
A. Patz, L.E. Hoech, E. De la Cruz.
Studies on the effect of high oxygen administration in retrolental fibroplasia.1. Nursery observations.
AMJ Ophthalmol, 35 (1952), pp. 1248-1253
[16.]
The STOP-ROP Multi-centre Study Group.
Supplemental thera-peutic oxygen for pre-threshold retinopathy of prematurity (STOP-ROP), a randomized controlled trial.
Pediatrics, 105 (2000), pp. 295-319
[17.]
L. Askie, D. Henderson-Smark, L. Irwig.
The effect of differing oxygen saturation targeting ranges on long-term growth and development of extremely preterm, oxygen dependent infants: The BOOST trial.
(Abstract) Pediatr Res, 51 (2002), pp. 387A
[18.]
W. Tin, S. Walker, C. Lacamp.
Oxygen monitoring in preterm babies: Too high, too low?.
Paed Respir Rev, 4 (2003), pp. 9-14
[19.]
C.K. Cunningham, J.A. McMillan, S.J. Gross.
Re-hospitalisation for respiratory illness in infants of less than 32 weeks gestation.
Pediatrics, 88 (1991), pp. 527-532
[20.]
A. Greenough, S. Cox, J. Alexander, W. Lenney, F. Turnbull, S. Bur-gess.
Healthcare utilisation of infants with chronic lung disease, related to hospitalisation for RSV infection.
Arch Dis Child, 85 (2001), pp. 463-468
[21.]
W. Lenney.
Healthcare utilisation of prematurely born, pres-chool children related to hospitalisation for RSV infection.
(Abstract) Am J Resp Crit Care Med, 167 (2003), pp. A721
[22.]
X. Carbonell-Estrany, J. Quero.
and the IRIS Study Group.Hos-pitalisation rates for respiratory syncytial virus (RSV) infection in premature infants born during two consecutive seasons.
Pediatr Infect Dis J, 20 (2001), pp. 874-879
[23.]
Impact RSV Study Group.
Palivizumab, a humanised respira-tory syncytial virus monoclonal antibody, reduces hospitalisa-tion from respiratory syncytial virus infection in high-risk infants.
Pediatrics, 102 (1998), pp. 531-537
[24.]
J. Peach, W. Lenney.
Can the use of an objective clinical scoring system improve the assessment of response to treatment in wheezing children under 2 years old.
Asthma J Dec, (2002), pp. 193-195
[25.]
H.L. Halliday, R.A. Ehrenkranz, L.W. Doyle.
Several different meta-analyses.
The Cochrane Library Issue 3,
[26.]
H. Bisgaard, S. Munck, J. Nielsen, W. Petersen, S.V. Ohlsson.
Inha-led busdesonide for treatment of current wheezing in early childhood.
Lancet, 336 (1990), pp. 649-651
[27.]
M.W. Beresford, R. Primhak, N.V. Subhedar.
Randomized, dou-ble-blind, placebo controlled trial of inhaled fluticasone pro-pionate in infants with chronic lung disease.
Arch Dis Child, 87 (2002), pp. F62-F63
[28.]
Statement on the Care of the Child with Chronic Lung Disease of Infancy and Childhood.
Am J Respir Crit Care Med, 168 (2003), pp. 356-396
[29.]
A. Rotschild, A. Solimano, M. Puterman, J. Smyth, A. Sharma, S. Albersheim.
Increased compliance in response to salbutamol in premature infants with developing bronchopulmonary dys-plasia.
J Pediatr, 115 (1989), pp. 984-991
[30.]
B. Yuksel, A. Greenough.
Comparison of the effects on lung function of two methods of bronchodilator administration.
Res-pir Med, 88 (1994), pp. 229-233
Copyright © 2004. Asociación Española de Pediatría
